Skip to content

PANDRH Working Groups

Working Group Pharmacovigilance

Develop and strengthen Pharmacovigilance through regulatory harmonization activities and proposals that promote the safety and rational use of drugs as a necessary component of public health policies in the Americas.


  1. Promote development and circulation of the knowledge, criteria, and methods used in Pharmacovigilance, which should be used in training and educational activities for all actors related to medicines; 
  2. Analyze and promote development of harmonization tools to support Pharmacovigilance in the Region;
  3. Develop and promote a network that permits exchange of knowledge, communication, and support for decision-making related to Pharmacovigilance;
  4. Promote integration of Pharmacovigilance as an essential component of medical programs and public health policies;
  5. Promote research on Pharmacovigilance and its circulation, as well as analysis of the impact of Pharmacovigilance on public health, emphasizing patient safety.

Working Group on Medicines Promotion

To promote and harmonize criteria for medicines promotion as a contribution to the rational use, within the scope of health policies in the Americas.

Broaden and strengthen the consciousness and responsibility related to medicines promotion.


  1. To provide mechanisms and criteria to identify irregularities and demonstrate the most used market strategies of medicines promotion in the American countries.   
  2. To provide information and analysis about regulation, implementation and monitoring related to medicines promotion.
  3. To promote educational activities and programs related to medicines promotion aimed at health professionals, potential and effective consumers.
  4. To evaluate the operation and impact of the activities of the WG.

    Working Group on Medicines Classification

    Mission, Objectives and Documents.


    Working Group on Good Manufacturing Practices

    Presents Mission, objectives and documents.


    Working Group on Good Clinical Practices

    Working Group on Good Clinical Practices documents, Mission and Objectives.

    Working Group on Medical Plants

    It presents the mission, objectives and documents.

    Working Group on Counterfeit Medicines

    Since its creation in 1999, the GT / CFM has focused on the formulation of proposals for the development of policies and strategies for implementation by countries, development and promotion of training programs for process optimization of inspection and capacity building/ investigation; and promoting the exchange of information. For more information click here

    To promote, facilitate, and motivate implementation of proactive strategies for preventing and fighting medicines counterfeiting and thus contribute to the improvement of health care in our countries in the Americas.

    Working Group on Good Laboratory Practices

    El PCEC mide el desempeño de los Laboratorios Oficiales de Control de Medicamentos de la región, enviándoles muestras ciegas para su análisis cuyos resultados son evaluados por la Farmacopea Norteamericana (USP).


    PANDRH Bioequivalence Working Group

    Contents: Bioequivalence Working Group´s Mission, objectives, background, recommendations, educational activities, working papers, and information resources.


    Regional Office for the Americas of the World Health Organization
    525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
    Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663

    © Pan American Health Organization. All rights reserved.